Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor
© Kitchens et al; licensee BioMed Central Ltd. 2011
Received: 2 August 2010
Accepted: 31 January 2011
Published: 31 January 2011
Midgut carcinoids are neuroendocrine tumors that commonly metastasize to the intestinal mesentery, where they predispose to intestinal obstruction, ischemia and/or congestion. Because of their location, many mesenteric carcinoid tumors are deemed unresectable due to the risk of uncontrollable bleeding and prolonged intestinal ischemia.
We report the case of a 60-year-old male with a mesenteric carcinoid tumor obstructing his superior mesenteric vein, resulting in intestinal varices and severe recurrent GI bleeds. While his tumor was thought to be unresectable by conventional techniques, it was successfully resected using intestinal autotransplantation to safely gain access to the tumor. This case is the first described application of this technique to carcinoid tumors.
Intestinal autotransplantation can be utilized to safely resect mesenteric carcinoid tumors from patients who were not previously thought to be surgical candidates. We review the literature concerning both carcinoid metastases to the intestinal mesentery and the use of intestinal autotransplantation to treat lesions involving the mesenteric root.
List of abbreviations
superior mesenteric artery
superior mesenteric vein
total parenteral nutrition
Carcinoid tumors are the most common neuroendocrine neoplasm, typically arising in the respiratory and midgut gastrointestinal tracts [1, 2]. While midgut carcinoid tumors are usually slow growing, they are often associated with severe complications from early metastasis to the liver and the small bowel mesentery . These mesenteric carcinoid tumors release serotonin and other growth factors which induce a desmoplastic reaction causing diffuse mesenteric fibrosis and encasement of critical mesenteric vasculature, which in turn predisposes to intestinal obstruction, hypoperfusion and/or congestion . Several groups have published surgical strategies for debulking mesenteric carcinoid disease [5–7]. However, complete encasement of the mesenteric vasculature has traditionally been considered an absolute contraindication to surgery given the risk of uncontrollable bleeding or inducing prolonged intestinal ischemia . Here we describe a novel technique to resect extensive mesenteric root carcinoid metastases using partial abdominal evisceration and intestinal autotransplantation.
His disease remained fairly stable for almost two years on octreotide, with only slight progressive enlargement of his mesenteric mass on interval abdominal CT scans. Starting in August 2007, however, he required multiple hospital admissions for GI bleeding. Colonoscopy was unremarkable, and an EGD showed thickened folds in the second portion of the duodenum. A video-capsule endoscopy revealed diffuse congested mucosa throughout the jejunum, with a few localized erosions. A push enteroscopy was performed, but his duodenal and jejunal varices were not amenable to intervention. By January 2008, he was requiring 2-4 units of red blood cell transfusions a week due to continued GI bleeding; a palliative care consult was obtained and preparations were made to proceed with home hospice. At this point he was referred for a second surgical opinion. Given his otherwise state of good health and his desire for aggressive treatment of his carcinoid tumor, it was determined that we should attempt a palliative resection including partial abdominal evisceration for resection of his mesenteric carcinoid tumor and reconstruction via intestinal autotransplantation.
Final pathology revealed well-differentiated multifocal carcinoid of the small bowel with metastases to the mesentery (where a 6.5 cm mass was identified) and mesenteric lymph nodes (9 of 18 nodes positive). All resection margins were negative for malignancy. By TNM staging (as defined by ENETS), his tumor was stage IIIB. The patient had a complicated post-operative course. A second-look laparotomy performed on postoperative day 1 revealed all of the bowel to be viable. The patient was brought back to the operating room on postoperative day 4 with plans to connect the cecum and descending colon. At this laparotomy, the ileojejunal segment of bowel looked dusky, albeit not frankly necrotic. The ileocolic segment remained pink and well-perfused. A near-occlusive clot was found at the superior mesenteric artery anastomosis. Fogarty thrombectomy restored good flow to that bowel segment. Continued acidosis and hemodynamic instability required re-exploration the next day, at which point a large thrombus was again palpated in the SMA, and the ileojejunal segment of bowel was found to be nonviable. This segment of transplanted bowel was therefore resected, requiring take-down of the pancreaticojejunostomy, choledochojejunostomy and gastrojejunostomy. Reconstruction could not be performed with the ileocecal segment of bowel in its current location, so this segment was explanted, flushed with ice-cold lactated Ringer solution containing mannitol and then kept on ice. The venotomy and arteriotomy on the vena cava and abdominal aorta were patched with pieces of ileal vein and artery, respectively. The ileocecal segment (including ~70 cm of ileum) was then revascularized via the superior mesenteric artery and vein. The bowel was pink immediately upon reperfusion. A pancreaticoileostomy, gastroileostomy and choledochoileostomy were then performed in the standard fashion. Reconstruction was completed by anastomosing the cecum to the descending colon (Figure 3B). Postoperatively, he was started on a heparin drip to prevent further thrombosis and he was successfully extubated the next day.
His subsequent hospital course was remarkable for periodic febrile episodes requiring first IR drain placement into a pelvic fluid collection (which grew Candida albicans) and a final laparotomy for abdominal washout with saline containing amphotericin B and gentamicin. He did have a small leak at his pancreaticoileostomy that was managed conservatively with NPO status and initiation of TPN. He was discharged on TPN on POD 72, tolerating some tube feeds and enteral intake.
Over the ensuing months the patient required several short hospitalizations for central venous line infections related to his TPN, in addition to endocarditis. He was ultimately weaned off parenteral nutrition and his weight has stabilized. He had recovered well enough to undergo an aortic valve replacement in December 2009. Currently, 2.5 years after his carcinoid resection, he is completely independent of parenteral nutrition or tube feeds. He continues to have mild diarrhea, well-controlled with cholestyramine. Surveillance abdominal CT scans reveal no evidence of carcinoid recurrence or metastasis, and his chromogranin A in March 2010 was within normal limits (93 ng/ml, reference < 225 ng/ml).
Of the gastrointestinal carcinoids, those arising from the midgut (e.g. small intestine and appendix) are by far the most common, with tumors distal to the jejunum representing 96% of carcinoids located in the gastrointestinal tract . These midgut carcinoids secrete serotonin and are responsible for the carcinoid syndrome, the intractable flushing and diarrhea associated with metastasis to the liver. In addition to hepatic metastasis, midgut carcinoids also commonly metastasize to the small bowel mesentery . Indeed, radiographic studies indicate mesenteric involvement in 40-80% of patients with abdominal carcinoid tumors [9–11].
Carcinoid metastases to the mesentery often grow far larger than the submucosal primary tumors in the small bowel wall, and they are responsible for much of the morbidity and mortality of gastrointestinal carcinoid tumor that is not attributable to carcinoid syndrome itself. Many patients with mesenteric carcinoid present with small bowel obstructive symptoms due to tethering and kinking of the small bowel to the rigid mesentery. In several surgical case series of patients with midgut carcinoids, 62-67% required laparotomy for either intestinal obstruction or abdominal pain, and of these patients, 67-79% had evidence of extensive mesenteric fibrosis upon surgical exploration [12, 13]. In other cases, the mesenteric vasculature (e.g. superior mesenteric artery and vein) can become completely encased in tumor, causing regional portal hypertension and arterial insufficiency [14–16]. The encasement of the visceral vasculature may manifest as episodes of post-prandial acute abdominal pain or as GI bleeds (noted in 5% of midgut carcinoid patients in one case series) [3, 13].
Although somatostatin analogs such as octreotide remain the mainstay of carcinoid therapy, surgical resection has emerged as a vital treatment in disease management. For metastatic disease, palliative cytoreductive surgery has been employed by some groups to specifically address mesenteric carcinoids. While some symptomatic improvement is often reported, long-term outcomes are compromised by recurrent disease [5, 17, 18]. Unfortunately, large mesenteric carcinoids have often been considered unresectable due to their position abutting critical vascular structures in the abdomen.
Recently, however, several groups have published reports outlining the use of intestinal autotransplantation to safely gain access and resect tumors that encase the vasculature of the mesenteric root. Utilizing techniques from intestinal allotransplantation, the patient's small intestine is harvested en bloc and maintained in cold preservative fluid to limit warm ischemia injury. The mesenteric mass is then fully excised, and the intestine is autotransplanted back into the patient. This strategy was first employed by David Lai and colleagues to treat a nonfunctioning islet cell carcinoma . That patient also underwent a total pancreatectomy, gastrectomy, splenectomy and hepatic revascularization (as his proximal hepatic artery was also resected). Vascular anastomoses were performed between the hepatic artery and aorta, distal superior mesenteric artery and aorta, and between the distal superior mesenteric vein and cephalad portal vein.
A similar approach was employed by Tzakis and colleagues to treat four patients with lesions involving the root of the mesentery. The indications for resection in these patients were pancreatic head fibroma, vascular malformation at the mesenteric root, desmoid tumor of the pancreatic tail, and locally advanced pancreatic adenocarcinoma [20, 21]. Whereas we employed in situ resection of the carcinoid tumor, the patients in Tzakis' case series had ex vivo resection of their lesions on ice on the back table after their organs had been removed en bloc. The mesenteric lesions of his series did not apparently extend into the distal branches of the SMA, obviating the need to autotransplant multiple segments of intestine as in the case we present here. All of his patients had good outcomes except for the patient treated for pancreatic cancer, who died of hepatic metastases 7 months postoperatively. Two additional case reports of intestinal autotransplantation to treat locally-advanced pancreatic cancer extending into the mesenteric root were also complicated by rapid recurrence of hepatic or peritoneal metastases, and early death after the procedure [22, 23]. These reports cast doubt on whether this aggressive surgical strategy is warranted for cases of pancreatic cancer.
Here we present the first description of partial abdominal evisceration and intestinal autotransplantation used to treat a mesenteric carcinoid tumor. This method may prove particularly useful for midgut carcinoid tumors, as this malignancy frequently extends into the mesenteric root, with enormous clinical consequences. While stenting of the superior mesenteric vein was recently described to palliate the symptoms of intestinal congestion that often accompany mesenteric spread of midgut carcinoids , intestinal autotransplantation permits tumor resection with possible curative results. In conjunction with earlier studies, this report demonstrates that intestinal autotransplantation is a surgical strategy that can be used to successfully treat a variety of lesions involving the mesenteric root, including many that were previously thought to be unresectable.
Written consent was obtained from the patient for publication of this case report and the accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
WHK is supported by an ASTS-Roche Laboratories Scientist Scholarship from the American Society of Transplant Surgeons.
- Woodside KJ, Townsend CM, Mark Evers B: Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg 2004, 8: 742–756.PubMedView Article
- Klöppel G, Perren A, Heitz PU: The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Annals of the New York Academy of Sciences 2004, 1014: 13–27.PubMedView Article
- Ohrvall U, Eriksson B, Juhlin C, Karacagil S, Rastad J, Hellman P, Akerström G: Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 2000, 24: 1402–1408.PubMedView Article
- Modlin IM, Shapiro MD, Kidd M: Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol 2004, 99: 2466–2478.PubMedView Article
- Akerström G, Hellman P: Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007, 21: 87–109.PubMedView Article
- Kerström G, Hellman P, Hessman O: Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol 2005, 19: 717–728.PubMedView Article
- Wang Y-Z, Joseph S, Lindholm E, Lyons J, Boudreaux JP, Woltering EA: Lymphatic mapping helps to define resection margins for midgut carcinoids. Surgery 2009, 146: 993–997.PubMedView Article
- Stinner B, Kisker O, Zielke A, Rothmund M: Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg 1996, 20: 183–188.PubMedView Article
- Gould M, Johnson RJ: Computed tomography of abdominal carcinoid tumour. Br J Radiol 1986, 59: 881–885.PubMedView Article
- Picus D, Glazer HS, Levitt RG, Husband JE: Computed tomography of abdominal carcinoid tumors. AJR Am J Roentgenol 1984, 143: 581–584.PubMed
- Druce MR, Bharwani N, Akker SA, Drake WM, Rockall A, Grossman AB: Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel. QJM 2010, 103: 177–185.PubMedView Article
- Morgan JG, Marks C, Hearn D: Carcinoid tumors of the gastrointestinal tract. Ann Surg 1974, 180: 720–727.PubMedView Article
- Makridis C, Rastad J, Oberg K, Akerström G: Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World J Surg 1996, 20: 900–906. discussion 907PubMedView Article
- Akerström G, Hellman P, Hessman O, Osmak L: Management of midgut carcinoids. J Surg Oncol 2005, 89: 161–169.PubMedView Article
- Eckhauser FE, Argenta LC, Strodel WE, Wheeler RH, Bull FE, Appelman HD, Thompson NW: Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 1981, 90: 720–728.PubMed
- Akerström G, Makridis C, Johansson H: Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol 1991, 30: 547–553.PubMedView Article
- Chambers AJ, Pasieka JL, Dixon E, Rorstad O: The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery 2008, 144: 645–651. discussion 651–643.PubMedView Article
- Boudreaux JP, Putty B, Frey DJ, Woltering E, Anthony L, Daly I, Ramcharan T, Lopera J, Castaneda W: Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg 2005, 241: 839–845. discussion 845–836.PubMedView Article
- Lai DT, Chu KM, Thompson JF, Gallagher JP, Waugh R, Storey DW, Stephen MS: Islet cell carcinoma treated by induction regional chemotherapy and radical total pancreatectomy with liver revascularization and small bowel autotransplantation. Surgery 1996, 119: 112–114.PubMedView Article
- Tzakis AG, De Faria W, Angelis M, Verzaro R, Pinna A: Partial abdominal exenteration, ex vivo resection of a large mesenteric fibroma, and successful orthotopic intestinal autotransplantation. Surgery 2000, 128: 486–489.PubMedView Article
- Tzakis AG, Tryphonopoulos P, De Faria W, Kato T, Nishida S, Levi DM, Madariaga J, Weppler D, Mittal N, Ruiz P, et al.: Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. J Am Coll Surg 2003, 197: 770–776.PubMedView Article
- Amano H, Miura F, Toyota N, Wada K, Katoh K-I, Hayano K, Kadowaki S, Shibuya M, Maeno S, Eguchi T, et al.: In situ surgical procedures for locally advanced pancreatic cancer: partial abdominal evisceration and intestinal autotransplantation. J Hepatobiliary Pancreat Surg 2009, 16: 771–776.PubMedView Article
- Quintini C, Di Benedetto F, Diago T, Lauro A, Cautero N, De Ruvo N, Romano A, Di Sandro S, Ramacciato G, Pinna AD: Intestinal autotransplantation for adenocarcinoma of pancreas involving the mesenteric root: our experience and literature review. Pancreas 2007, 34: 266–268.PubMedView Article
- Hellman P, Hessman O, Akerström G, Stålberg P, Hennings J, Björck M, Eriksson L-G: Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses. World J Surg 2010, 34: 1373–1379.PubMedView Article
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.